These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 25912534)

  • 1. N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review.
    Oliver G; Dean O; Camfield D; Blair-West S; Ng C; Berk M; Sarris J
    Clin Psychopharmacol Neurosci; 2015 Apr; 13(1):12-24. PubMed ID: 25912534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "N-Acetylcysteine for Obsessive-Compulsive and Related Disorders in Children and Adolescents: A Review".
    Parli GM; Gales MA; Gales BJ
    Ann Pharmacother; 2023 Jul; 57(7):847-854. PubMed ID: 36384314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Future Role Might N-Acetyl-Cysteine Have in the Treatment of Obsessive Compulsive and Grooming Disorders?: A Systematic Review.
    Smith L; Tracy DK; Giaroli G
    J Clin Psychopharmacol; 2016 Feb; 36(1):57-62. PubMed ID: 26629962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study.
    Sarris J; Oliver G; Camfield DA; Dean OM; Dowling N; Smith DJ; Murphy J; Menon R; Berk M; Blair-West S; Ng CH
    CNS Drugs; 2015 Sep; 29(9):801-9. PubMed ID: 26374743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential of
    Lee DK; Lipner SR
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35681955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Acetyl Cysteine and Vitamin D Supplementation in Treatment Resistant Obsessive-compulsive Disorder Patients: A General Review.
    di Michele F; Siracusano A; Talamo A; Niolu C
    Curr Pharm Des; 2018; 24(17):1832-1838. PubMed ID: 29663874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral N-acetylcysteine in the treatment of obsessive-compulsive disorder: A systematic review of the clinical evidence.
    Couto JP; Moreira R
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():245-254. PubMed ID: 29908912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
    Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of N-acetylcysteine in the treatment of grooming disorders.
    Braun TL; Patel V; DeBord LC; Rosen T
    Int J Dermatol; 2019 Apr; 58(4):502-510. PubMed ID: 30667049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders.
    Bradlow RCJ; Berk M; Kalivas PW; Back SE; Kanaan RA
    CNS Drugs; 2022 May; 36(5):451-482. PubMed ID: 35316513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine blocks serotonin 1B agonist-induced OCD-related behavior in mice.
    Allen EM; Hughes EF; Anderson CJ; Woehrle NS
    Behav Neurosci; 2018 Aug; 132(4):258-268. PubMed ID: 29985009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of biofeedback approaches for obsessive-compulsive and related disorders: A systematic review and meta-analysis.
    Ferreira S; Pêgo JM; Morgado P
    Psychiatry Res; 2019 Feb; 272():237-245. PubMed ID: 30590278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of postpartum obsessive-compulsive disorder: a systematic review.
    Sharma V
    Expert Rev Neurother; 2018 Dec; 18(12):925-931. PubMed ID: 30451547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family functioning in paediatric obsessive compulsive and related disorders.
    Murphy YE; Flessner CA
    Br J Clin Psychol; 2015 Nov; 54(4):414-34. PubMed ID: 26017183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylcysteine as a new prominent approach for treating psychiatric disorders.
    Smaga I; Frankowska M; Filip M
    Br J Pharmacol; 2021 Jul; 178(13):2569-2594. PubMed ID: 33760228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of N-Acetylcysteine Augmentation on Obsessive Compulsive Disorder: A Multicenter Randomized Double Blind Placebo Controlled Clinical Trial.
    Ghanizadeh A; Mohammadi MR; Bahraini S; Keshavarzi Z; Firoozabadi A; Alavi Shoshtari A
    Iran J Psychiatry; 2017 Apr; 12(2):134-141. PubMed ID: 28659986
    [No Abstract]   [Full Text] [Related]  

  • 17. A Double-Blind Randomized Placebo-Controlled Pilot Study of Azithromycin in Youth with Acute-Onset Obsessive-Compulsive Disorder.
    Murphy TK; Brennan EM; Johnco C; Parker-Athill EC; Miladinovic B; Storch EA; Lewin AB
    J Child Adolesc Psychopharmacol; 2017 Sep; 27(7):640-651. PubMed ID: 28358599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive Behaviors Treated With N-Acetylcysteine: Case Series.
    Kiliç F; Keleş S
    Clin Neuropharmacol; 2019; 42(4):139-141. PubMed ID: 31232748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Habit Reversal Therapy in Obsessive Compulsive Related Disorders: A Systematic Review of the Evidence and CONSORT Evaluation of Randomized Controlled Trials.
    Lee MT; Mpavaenda DN; Fineberg NA
    Front Behav Neurosci; 2019; 13():79. PubMed ID: 31105537
    [No Abstract]   [Full Text] [Related]  

  • 20. Dorsal anterior cingulotomy and anterior capsulotomy for severe, refractory obsessive-compulsive disorder: a systematic review of observational studies.
    Brown LT; Mikell CB; Youngerman BE; Zhang Y; McKhann GM; Sheth SA
    J Neurosurg; 2016 Jan; 124(1):77-89. PubMed ID: 26252455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.